EP 97 “Ozempic Face" in Aesthetic patients: The skinny on Semaglutide and Beyond
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
GLP-1 medications like semaglutide and tirzepatide — better known as Ozempic, Wegovy, and Mounjaro — are transforming lives through significant weight loss. But along with the health benefits, many patients notice unexpected changes in their appearance: facial hollowing, skin laxity, and body deflation, often referred to as “Ozempic face.”
In this episode of The Aesthetic Doctor Podcast, Dr. Judith Borger explores how GLP-1s affect both the face and body — and what can be done to support our weight loss patients through these changes. Whether you’re a a patient curious about safe, effective ways to restore balance and confidence or a provider looking to expand your toolkit of non-surgical treatment, this conversation offers practical strategies, safety insights, and compassionate guidance for navigating the GLP-1 journey.
Dr. Judith Borger Links: